TY - JOUR AU - Sethi, S. PY - 2010 DA - 2010// TI - Infection as a comorbidity of COPD JO - Eur Respir J VL - 35 UR - https://doi.org/10.1183/09031936.00081409 DO - 10.1183/09031936.00081409 ID - Sethi2010 ER - TY - JOUR AU - Witzenrath, M. B. AU - Gutbier, A. C. AU - Hocke, B. AU - Schmeck, S. AU - Hippenstiel, K. AU - Berger, T. J. AU - Mitchell, J. R. AU - DeLos Toyos, S. AU - Rosseau, N. AU - Suttorp, H. AU - Schutte PY - 2006 DA - 2006// TI - Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000220496.48295.A9 DO - 10.1097/01.CCM.0000220496.48295.A9 ID - Witzenrath2006 ER - TY - JOUR AU - Matthay, M. A. AU - Ware, L. B. AU - Zimmerman, G. A. PY - 2012 DA - 2012// TI - The acute respiratory distress syndrome JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI60331 DO - 10.1172/JCI60331 ID - Matthay2012 ER - TY - JOUR AU - Shaykhiev, R. AU - Bals, R. PY - 2007 DA - 2007// TI - Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis JO - J Leukoc Biol VL - 82 UR - https://doi.org/10.1189/jlb.0207096 DO - 10.1189/jlb.0207096 ID - Shaykhiev2007 ER - TY - JOUR AU - Bals, R. AU - Weiner, D. J. AU - Wilson, J. M. PY - 1999 DA - 1999// TI - The innate immune system in cystic fibrosis lung disease JO - J Clin Invest VL - 103 UR - https://doi.org/10.1172/JCI6277 DO - 10.1172/JCI6277 ID - Bals1999 ER - TY - JOUR AU - Sethi, S. AU - Murphy, T. F. PY - 2008 DA - 2008// TI - Infection in the pathogenesis and course of chronic obstructive pulmonary disease JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMra0800353 DO - 10.1056/NEJMra0800353 ID - Sethi2008 ER - TY - JOUR AU - Dubin, P. J. AU - Martz, A. AU - Eisenstatt, J. R. AU - Fox, M. D. AU - Logar, A. AU - Kolls, J. K. PY - 2012 DA - 2012// TI - Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection JO - Infect Immun VL - 80 UR - https://doi.org/10.1128/IAI.05821-11 DO - 10.1128/IAI.05821-11 ID - Dubin2012 ER - TY - JOUR AU - Dalhoff, A. PY - 2005 DA - 2005// TI - Immunomodulatory activities of fluoroquinolones JO - Infection VL - 33 UR - https://doi.org/10.1007/s15010-005-8209-8 DO - 10.1007/s15010-005-8209-8 ID - Dalhoff2005 ER - TY - JOUR AU - Wilson, R. AU - Anzueto, A. AU - Miravitlles, M. AU - Arvis, P. AU - Alder, J. AU - Haverstock, D. AU - Trajanovic, M. AU - Sethi, S. PY - 2012 DA - 2012// TI - Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results JO - Eur Respir J VL - 40 UR - https://doi.org/10.1183/09031936.00090311 DO - 10.1183/09031936.00090311 ID - Wilson2012 ER - TY - JOUR AU - Lister, P. D. AU - Sanders, C. C. PY - 2001 DA - 2001// TI - Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae JO - J Antimicrob Chemother VL - 47 UR - https://doi.org/10.1093/jac/47.6.811 DO - 10.1093/jac/47.6.811 ID - Lister2001 ER - TY - JOUR AU - Woodcock, J. M. AU - Andrews, J. M. AU - Boswell, F. J. AU - Brenwald, N. P. AU - Wise, R. PY - 1997 DA - 1997// TI - In vitro activity of BAY 12-8039, a new fluoroquinolone JO - Antimicrob Agents Chemother VL - 41 ID - Woodcock1997 ER - TY - JOUR AU - Zhang, L. AU - Li, X. Z. AU - Poole, K. PY - 2001 DA - 2001// TI - Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia JO - J Antimicrob Chemother VL - 48 UR - https://doi.org/10.1093/jac/48.4.549 DO - 10.1093/jac/48.4.549 ID - Zhang2001 ER - TY - JOUR AU - Buyck, J. M. AU - Tulkens, P. M. AU - Van, B. F. PY - 2013 DA - 2013// TI - Pharmacodynamic evaluation of the intracellular activity of antibiotics towards Pseudomonas aeruginosa PAO1 in a model of THP-1 human monocytes JO - Antimicrob Agents Chemother VL - 57 UR - https://doi.org/10.1128/AAC.02609-12 DO - 10.1128/AAC.02609-12 ID - Buyck2013 ER - TY - JOUR AU - Araujo, F. G. AU - Slifer, T. L. AU - Remington, J. S. PY - 2002 DA - 2002// TI - Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide JO - Clin Microbiol Infect VL - 8 UR - https://doi.org/10.1046/j.1469-0691.2002.00374.x DO - 10.1046/j.1469-0691.2002.00374.x ID - Araujo2002 ER - TY - JOUR AU - Weiss, T. AU - Shalit, I. AU - Blau, H. AU - Werber, S. AU - Halperin, D. AU - Levitov, A. AU - Fabian, I. PY - 2004 DA - 2004// TI - Anti-inflammatory effects of moxifloxacin on activated human monocytic cells: inhibition of NF-kappaB and mitogen-activated protein kinase activation and of synthesis of proinflammatory cytokines JO - Antimicrob Agents Chemother VL - 48 UR - https://doi.org/10.1128/AAC.48.6.1974-1982.2004 DO - 10.1128/AAC.48.6.1974-1982.2004 ID - Weiss2004 ER - TY - JOUR AU - Choi, J. H. AU - Song, M. J. AU - Kim, S. H. AU - Choi, S. M. AU - Lee, D. G. AU - Yoo, J. H. AU - Shin, W. S. PY - 2003 DA - 2003// TI - Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells JO - Antimicrob Agents Chemother VL - 47 UR - https://doi.org/10.1128/AAC.47.12.3704-3707.2003 DO - 10.1128/AAC.47.12.3704-3707.2003 ID - Choi2003 ER - TY - JOUR AU - Werber, S. AU - Shalit, I. AU - Fabian, I. AU - Steuer, G. AU - Weiss, T. AU - Blau, H. PY - 2005 DA - 2005// TI - Moxifloxacin inhibits cytokine-induced MAP kinase and NF-kappaB activation as well as nitric oxide synthesis in a human respiratory epithelial cell line JO - J Antimicrob Chemother VL - 55 UR - https://doi.org/10.1093/jac/dkh525 DO - 10.1093/jac/dkh525 ID - Werber2005 ER - TY - JOUR AU - Blau, H. AU - Klein, K. AU - Shalit, I. AU - Halperin, D. AU - Fabian, I. PY - 2007 DA - 2007// TI - Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line JO - Am J Physiol Lung Cell Mol Physiol VL - 292 UR - https://doi.org/10.1152/ajplung.00030.2006 DO - 10.1152/ajplung.00030.2006 ID - Blau2007 ER - TY - JOUR AU - Dalhoff, A. AU - Shalit, I. PY - 2003 DA - 2003// TI - Immunomodulatory effects of quinolones JO - Lancet Infect Dis VL - 3 UR - https://doi.org/10.1016/S1473-3099(03)00658-3 DO - 10.1016/S1473-3099(03)00658-3 ID - Dalhoff2003 ER - TY - JOUR AU - Bailly, S. AU - Fay, M. AU - Roche, Y. AU - Gougerot-Pocidalo, M. A. PY - 1990 DA - 1990// TI - Effects of quinolones on tumor necrosis factor production by human monocytes JO - Int J Immunopharmacol VL - 12 UR - https://doi.org/10.1016/0192-0561(90)90065-U DO - 10.1016/0192-0561(90)90065-U ID - Bailly1990 ER - TY - JOUR AU - Riesbeck, K. AU - Forsgren, A. AU - Henriksson, A. AU - Bredberg, A. PY - 1998 DA - 1998// TI - Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes JO - Antimicrob Agents Chemother VL - 42 ID - Riesbeck1998 ER - TY - JOUR AU - Ratner, A. J. AU - Lysenko, E. S. AU - Paul, M. N. AU - Weiser, J. N. PY - 2005 DA - 2005// TI - Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces JO - Proc Natl Acad Sci U S A VL - 102 UR - https://doi.org/10.1073/pnas.0500599102 DO - 10.1073/pnas.0500599102 ID - Ratner2005 ER - TY - JOUR AU - Beisswenger, C. AU - Kandler, K. AU - Hess, C. AU - Garn, H. AU - Felgentreff, K. AU - Wegmann, M. AU - Renz, H. AU - Vogelmeier, C. AU - Bals, R. PY - 2006 DA - 2006// TI - Allergic airway inflammation inhibits pulmonary antibacterial host defense JO - J Immunol VL - 177 UR - https://doi.org/10.4049/jimmunol.177.3.1833 DO - 10.4049/jimmunol.177.3.1833 ID - Beisswenger2006 ER - TY - JOUR AU - Pfaffl, M. W. PY - 2001 DA - 2001// TI - A new mathematical model for relative quantification in real-time RT-PCR JO - Nucleic Acids Res VL - 29 UR - https://doi.org/10.1093/nar/29.9.e45 DO - 10.1093/nar/29.9.e45 ID - Pfaffl2001 ER - TY - JOUR AU - Hess, C. AU - Herr, C. AU - Beisswenger, C. AU - Zakharkina, T. AU - Schmid, R. M. AU - Bals, R. PY - 2010 DA - 2010// TI - Myeloid RelA regulates pulmonary host defense networks JO - Eur Respir J VL - 35 UR - https://doi.org/10.1183/09031936.00196408 DO - 10.1183/09031936.00196408 ID - Hess2010 ER - TY - JOUR AU - Ewig, S. AU - Hecker, H. AU - Suttorp, N. AU - Marre, R. AU - Welte, T. PY - 2011 DA - 2011// TI - Moxifloxacin monotherapy versus ss-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia JO - J Infect VL - 62 UR - https://doi.org/10.1016/j.jinf.2011.01.009 DO - 10.1016/j.jinf.2011.01.009 ID - Ewig2011 ER - TY - JOUR AU - Kazama, I. AU - Tamada, T. AU - Nakajima, T. PY - 2012 DA - 2012// TI - Resolution of migratory pulmonary infiltrates by moxifloxacin in a patient with dual infection of Mycoplasma pneumoniae and Bordetella pertussis JO - Infez Med VL - 20 ID - Kazama2012 ER - TY - JOUR AU - Shalit, I. AU - Horev-Azaria, L. AU - Fabian, I. AU - Blau, H. AU - Kariv, N. AU - Shechtman, I. AU - Alteraz, H. AU - Kletter, Y. PY - 2002 DA - 2002// TI - Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.8.2442-2449.2002 DO - 10.1128/AAC.46.8.2442-2449.2002 ID - Shalit2002 ER - TY - JOUR AU - Pfeifer, P. AU - Voss, M. AU - Wonnenberg, B. AU - Hellberg, J. AU - Seiler, F. AU - Lepper, P. M. AU - Bischoff, M. AU - Langer, F. AU - Schafers, H. J. AU - Menger, M. D. AU - Bals, R. AU - Beisswenger, C. PY - 2013 DA - 2013// TI - IL-17C is a mediator of respiratory epithelial innate immune response JO - Am J Respir Cell Mol Biol VL - 48 UR - https://doi.org/10.1165/rcmb.2012-0232OC DO - 10.1165/rcmb.2012-0232OC ID - Pfeifer2013 ER - TY - JOUR AU - Sander, L. E. AU - Davis, M. J. AU - Boekschoten, M. V. AU - Amsen, D. AU - Dascher, C. C. AU - Ryffel, B. AU - Swanson, J. A. AU - Muller, M. AU - Blander, J. M. PY - 2011 DA - 2011// TI - Detection of prokaryotic mRNA signifies microbial viability and promotes immunity JO - Nature VL - 474 UR - https://doi.org/10.1038/nature10072 DO - 10.1038/nature10072 ID - Sander2011 ER -